NEWS & RESOURCES
FEATURED IN
GenomeWeb | Clinical Research News | Bio-IT World | Massey Comprehensive Cancer Center
SCIENTIFIC LEADERSHIP
Human Cell Atlas | HuBMAP | Chan Zuckerberg Initiative | Global Tissue Atlas Programs
Massey Comprehensive Cancer Center · March 23, 2026
Coverage of a Human Cell Atlas-aligned multimodal oral tissue atlas integrating millions of cells across healthy and diseased tissue.
Read ArticleMoleculent · November 6, 2025
Stratica was selected as an early-access collaborator supporting next-generation technologies designed to characterize multicellular communication and tissue organization at unprecedented scale.
Read ArticleGenomeWeb · August 12, 2025
Discussion of opportunities and challenges associated with the clinical translation of spatial biology technologies, including applications in biomarker discovery, patient stratification, and precision medicine.
Read ArticleFOUNDATIONAL PLATFORM TECHNOLOGIES
TACIT
Nature Communications, 2025
AI-enabled cell type and cell state identification across spatial multiomics and multiplexed imaging platforms.
STARComm
Submitted to Nucleic Acids Research
Spatial cell-cell communication and multicellular interaction modeling.
DISEASE FOUNDATION MODELS & BIOLOGICAL REFERENCE SYSTEMS
Adult Human Oral Cavity Atlas
Cell Press Blue / Human Cell Atlas Collection
Patients, Papers, and Platforms: A Non-Linear Path Through Clinic, Academia, and Industry
Keynote Speaker, Duke University Accelerate to Industry (A2i) Spring Immersion Day
From Platform to Pipeline: Spatial Biology as the Engine of Therapeutic Target Discovery
Keynote Speaker, 10x Genomics Global Sales Meeting; Speaker, 10x Atera Road Show
From Slides to Systems: Building Integrated AI Models of Human Disease
Invited Presentation, Quanterix Leadership and Sales Team
AREAS OF EXPERTISE
Publications, Preprints & Abstracts
Scientific contributions spanning spatial biology, computational medicine, disease atlases, biomarker discovery, and precision therapeutics.
Atlas Leadership
Leadership and contributions across Human Cell Atlas, HuBMAP, Chan Zuckerberg Initiative-supported programs, and large-scale biological atlas efforts.
Platform Validation Programs
StraticaOS technologies applied across oncology, immunology, inflammatory disease, rare disease, spatial biology, translational medicine, and precision therapeutic development.
Oncology
Using spatial proteomics, digital pathology, and AI-powered tissue modeling, Stratica identified responder-associated tumor ecosystems and biomarker candidates linked to clinical outcomes.
Read Case StudyAutoimmune Disease
Using multimodal tissue profiling and biological intelligence modeling, Stratica identified disease-driving pathways, supported therapeutic nomination, and leveraged longitudinal clinical trial tissues to discover biomarkers.
Read Case StudyInflammatory Disease
Using longitudinal single-cell immune profiling and computational disease modeling, Stratica generated mechanistic evidence supporting therapeutic activity and identified candidate translational biomarkers.
Read Case StudyFibrotic Disease
Stratica coordinated tissue access, regulatory approvals, pathology review, multimodal spatial profiling, and computational disease modeling to support a patient-specific precision medicine program.
Read Case StudyOncology
Stratica coordinated biopharma partners, technology providers, CROs, pathology teams, and computational workflows to generate a large-scale pan-cancer spatial atlas spanning twelve malignancies.
Read Case StudyWhether you are evaluating biological intelligence platforms, developing a therapeutic program, building disease foundation models, or exploring collaboration opportunities, our scientific team would be happy to connect.
